These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23622421)

  • 1. Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease.
    Padilla-Ibarra J; Sanchez-Ortiz A; Sandoval-Castro C; Ramos-Remus C
    Clin Exp Rheumatol; 2013; 31(4):657-8. PubMed ID: 23622421
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.
    Guilleminault L; Laurent S; Foucher A; Poubeau P; Paganin F
    BMC Pulm Med; 2016 May; 16(1):72. PubMed ID: 27160441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy.
    Lee WS; Yoo WH
    Rheumatology (Oxford); 2014 Sep; 53(9):1717-8. PubMed ID: 24643525
    [No Abstract]   [Full Text] [Related]  

  • 4. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
    Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
    Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
    Forestier E; Pasquali JL
    Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients.
    Pirildar T
    Clin Rheumatol; 2003 May; 22(2):157. PubMed ID: 12740686
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
    Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
    Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical predictors in chronic articular adult-onset Still's disease: comment on the article by Ichida et al.
    Colina M; Trotta F
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1127. PubMed ID: 24339332
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of refractory adult onset Still's disease with rituximab.
    Belfeki N; Smiti Khanfir M; Said F; Hamzaoui A; Ben Salem T; Ben Ghorbel I; Lamloum M; Houman MH
    Reumatismo; 2016 Dec; 68(3):159-162. PubMed ID: 27981819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of anakinra in adult-onset Still's disease myocarditis.
    Piel-Julian ML; Moulis G; Fournier P; Dupont R; Geiger D; Astudillo L; Faurie T; Pozzo J; Petermann A; Lairez O; Pugnet G; Sailler L
    Scand J Rheumatol; 2018 Nov; 47(6):511-512. PubMed ID: 29291663
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease.
    Her MY; Kim TH; Chang HK; Lee WS; Yoo DH
    Rheumatol Int; 2007 Jan; 27(3):295-8. PubMed ID: 16957888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 Inhibitors and Dacryoadenitis in Adult-Onset Still Disease.
    Breillat P; Tourte M; Romero P; Hayem G; Padovano I; Costantino F; Breban M
    Ann Intern Med; 2018 Mar; 168(6):455-456. PubMed ID: 29230477
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
    Raffeiner B; Botsios C; Dinarello C; Ometto F; Punzi L; Ramonda R
    Joint Bone Spine; 2011 Jan; 78(1):100-1. PubMed ID: 21036649
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
    Choi AD; Moles V; Fuisz A; Weissman G
    Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
    Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
    Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
    [No Abstract]   [Full Text] [Related]  

  • 16. A SEVERE CASE OF ADULT ONSET STILLS DISEASE WITH MYOPERICARDITIS, RESISTANT TO TREATMENT WITH TOCILIZUMAB BUT RESPONSIVE TO ANAKINRA.
    Waghmare S; Valecka B; Cairns AP
    Ulster Med J; 2015 May; 84(2):130-2. PubMed ID: 26376493
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody.
    Bartoloni E; Alunno A; Luccioli F; Santoboni G; Gerli R
    Clin Exp Rheumatol; 2009; 27(5):888-9. PubMed ID: 19917180
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
    Kadavath S; Zapantis E; Zolty R; Efthimiou P
    Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory adult onset Still's disease with rituximab.
    Ahmadi-Simab K; Lamprecht P; Jankowiak C; Gross WL
    Ann Rheum Dis; 2006 Aug; 65(8):1117-8. PubMed ID: 16837497
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous polyarteritis nodosa in adult onset Still's disease.
    Mylona E; Vadala C; Papadakos V; Loverdos D; Samarkos M; Skoutelis A
    Eur J Dermatol; 2009; 19(6):621-2. PubMed ID: 19592325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.